Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,369,745 papers from all fields of science
Search
Sign In
Create Free Account
CHRNG gene
Known as:
CHOLINERGIC RECEPTOR, NICOTINIC, GAMMA POLYPEPTIDE
, ACHRG
, CHRNG
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
CHRNB4 gene
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Utilization of Whole Exome Sequencing in Lethal Form of Multiple Pterygium Syndrome: Identification of Mutations in Embryonal Subunit of Acetylcholine Receptor
T. Nazari
,
A. Rashidi-Nezhad
,
+4 authors
J. Tavakkoly Bazzaz
International journal of molecular and cellular…
2019
Corpus ID: 216575574
The acetylcholine receptor (AChR) is a member of the superfamily of transmitter-gated ion channels having a critical role in…
Expand
2018
2018
Molecular Diagnosis of Rare Autosomal Recessive Escobar Syndrome in a Consanguineous Pakistani Family.
Gulab Sher
,
M. Naeem
Genetic Testing and Molecular Biomarkers
2018
Corpus ID: 53946083
BACKGROUND Escobar syndrome, a nonlethal variant of multiple pterygium syndromes (MPS), is a rare autosomal recessive disorder…
Expand
2017
2017
Clinical and molecular genetics of the multiple pterygium syndromes
J. Vogt
2017
Corpus ID: 78655865
The multiple pterygium syndromes are a heterogeneous group of conditions in which arthrogryposis (joint contractures), pterygia…
Expand
2016
2016
Truncating CHRNG mutations associated with interfamilial variability of the severity of the Escobar variant of multiple pterygium syndrome
A. Kariminejad
,
Navid Almadani
,
A. Khoshaeen
,
Björn Olsson
,
A. Moslemi
,
H. Tajsharghi
BMC Genetics
2016
Corpus ID: 255779109
In humans, muscle-specific nicotinergic acetylcholine receptor (AChR) is a transmembrane protein with five different subunits…
Expand
2013
2013
Clinical phenotype and the lack of mutations in the CHRNG, CHRND, and CHRNA1 genes in two Indian families with Escobar syndrome
Srinivas Kodaganur
,
S. Tontanahal
,
A. Sarda
,
M. H. Shah
,
V. Bhat
,
Arun Kumar
Clinical Dysmorphology
2013
Corpus ID: 36466150
The objective of this study was to report the clinical phenotype and genetic analysis of two Indian families with Escobar…
Expand
2013
2013
Is Webbing (Pterygia) a Constant Feature in Patients with Escobar Syndrome?
A. Al Kaissi
,
V. Kenis
,
+4 authors
F. Grill
Orthopaedic Surgery
2013
Corpus ID: 206235163
We describe two unrelated patients aged 9 and 12 years. The first patient presented with multiple congenital contractures not…
Expand
2011
2011
Associations of nicotine intake measures with CHRN genes in Finnish smokers.
Kaisu Keskitalo‐Vuokko
,
J. Pitkäniemi
,
+8 authors
J. Kaprio
Nicotine & Tobacco Research
2011
Corpus ID: 36134601
INTRODUCTION Genetic effects contribute to individual differences in smoking behavior. Persistence to smoke despite known harmful…
Expand
Highly Cited
2009
Highly Cited
2009
Absence of β-tropomyosin is a new cause of Escobar syndrome associated with nemaline myopathy
N. Monnier
,
J. Lunardi
,
+4 authors
P. Jouk
Neuromuscular Disorders
2009
Corpus ID: 38985021
2009
2009
Further characterization of a somatic cell hybrid panel: ten new assignments to the bovine genome.
G. Guérin
,
A. Eggen
,
+4 authors
M. Ferrara
Animal Genetics
2009
Corpus ID: 19195424
Thirty-six partially characterized hamster-bovine hybrid cell lines were used for the determination of synteny groups. Sixteen…
Expand
2009
2009
A genome-wide linkage scan in Tunisian families identifies a novel locus for non-syndromic posterior microphthalmia to chromosome 2q37.1
Mounira Hmani-Aifa
,
Salma Ben Salem
,
+8 authors
H. Ayadi
Human Genetics
2009
Corpus ID: 23210602
Posterior microphthalmia (PM) is a relatively rare autosomal recessive condition with normal anterior segment and small posterior…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE